Clinical Trial Update: XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + Dasatinib [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of capecitabine and oxaliplatin (Xelox) with bevacizumab and dasatinib in patients with solid tumors and metastatic c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Sprycel (dasatinib)
• Xeloda (capecitabine)

Snippet

Sponsor: Herbert Hurwitz, MD | Conditions: Solid Tumor, Metastatic Colorectal Cancer | Phase 1 | Status: COMPLETED